The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
FREEDOM: A phase 3b efficacy and safety study of fedratinib in intermediate- or high-risk myelofibrosis patients previously treated with ruxolitinib.
 
Srdan Verstovsek
Consulting or Advisory Role - Celgene; Constellation Pharmaceuticals; Incyte; Novartis; Pragmatist; Sierra Oncology
Research Funding - Blueprint Medicines; Celgene; CTI BioPharma Corp; Genentech; Gilead Sciences; Incyte; Novartis; NS Pharma; Promedior; Roche
 
Claire N. Harrison
Honoraria - Celgene; CTI BioPharma Corp; Gilead Sciences; Novartis; Shire
Speakers' Bureau - CTI BioPharma Corp; Gilead Sciences; Incyte; Novartis; Shire
Research Funding - Celgene (Inst); Novartis (Inst)
 
Giovanni Barosi
No Relationships to Disclose
 
Jean-Jacques Kiladjian
Consulting or Advisory Role - AOP Orphan Pharmaceuticals; Celgene; Novartis
Research Funding - AOP Orphan Pharmaceuticals (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Gilead Sciences
 
Daniela Buglio
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Vincent Chia
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Torsten Gerike
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Valerie Jessent-Ciaravino
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Joseph Mostillo
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Jun Zhang
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Ruben A. Mesa
Honoraria - AOP Orphan Pharmaceuticals; Novartis; shire
Consulting or Advisory Role - Baxalta; Galena Biopharma; Incyte; Novartis
Research Funding - Celgene (Inst); CTI (Inst); Genentech (Inst); Gilead Sciences (Inst); Incyte (Inst); NS Pharma (Inst); Pfizer (Inst); Pharmaessentia (Inst); Promedior (Inst)
Travel, Accommodations, Expenses - AOP Orphan Pharmaceuticals; Incyte; Novartis